EXACT Sciences Company Insiders
| EXAS Stock | USD 48.77 0.28 0.58% |
Slightly above 75% of EXACT Sciences' corporate insiders are selling. The analysis of the overall insider sentiment regarding EXACT Sciences suggests that many insiders are alarmed. EXACT Sciences employs about 6.9 K people. The company is managed by 28 executives with a total tenure of roughly 34 years, averaging almost 1.0 years of service per executive, having 246.43 employees per reported executive.
| Kevin Conroy Chairman Chairman of The Board, CEO and Pres |
Insider Sentiment 25
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-06-13 | Katherine S Zanotti | Disposed 3207 @ 53.2 | View | ||
| 2024-11-13 | Kevin T Conroy | Acquired 19500 @ 51.35 | View | ||
| 2024-10-08 | Brian Baranick | Disposed 929 @ 70 | View | ||
| 2024-09-18 | Brian Baranick | Disposed 929 @ 70 | View |
Monitoring EXACT Sciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. EXACT Sciences' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with EXACT Sciences' future performance. Based on our forecasts, it is anticipated that EXACT will maintain a workforce of slightly above 6900 employees by August 2025.EXACT Sciences' latest congressional trading
Congressional trading in companies like EXACT Sciences, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in EXACT Sciences by those in governmental positions are based on the same information available to the general public.
| 2020-11-20 | Representative Jim Hagedorn | Acquired Under $15K | Verify |
EXACT Sciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.0183) % which means that it has lost $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3689) %, meaning that it created substantial loss on money invested by shareholders. EXACT Sciences' management efficiency ratios could be used to measure how well EXACT Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.42 in 2025. Return On Capital Employed is likely to drop to -0.21 in 2025. At this time, EXACT Sciences' Intangibles To Total Assets are comparatively stable compared to the past year. Debt To Assets is likely to gain to 0.49 in 2025, whereas Return On Tangible Assets are likely to drop (0.42) in 2025.Common Stock Shares Outstanding is likely to gain to about 193.4 M in 2025, despite the fact that Net Loss is likely to grow to (533.1 M).
EXACT Sciences Workforce Comparison
EXACT Sciences is rated # 2 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 24,587. EXACT Sciences totals roughly 6,900 in number of employees claiming about 28% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.12. EXACT Sciences Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXACT Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXACT Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, EXACT Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-06-01 | 1.25 | 5 | 4 | 40,684 | 35,307 |
| 2025-03-01 | 0.68 | 34 | 50 | 492,146 | 318,593 |
| 2024-12-01 | 1.0 | 1 | 1 | 19,500 | 929.00 |
| 2024-09-01 | 1.0 | 3 | 3 | 45,514 | 5,016 |
| 2024-06-01 | 2.7273 | 30 | 11 | 109,209 | 56,381 |
| 2024-03-01 | 0.6377 | 44 | 69 | 583,817 | 313,953 |
| 2023-12-01 | 1.0 | 4 | 4 | 33,266 | 42,511 |
| 2023-09-01 | 0.1429 | 1 | 7 | 2,712 | 44,463 |
| 2023-06-01 | 1.5556 | 14 | 9 | 40,537 | 22,116 |
| 2023-03-01 | 0.6441 | 38 | 59 | 336,022 | 230,824 |
| 2022-12-01 | 0.4 | 2 | 5 | 35,006 | 54,739 |
| 2022-09-01 | 0.6 | 3 | 5 | 7,648 | 21,416 |
| 2022-06-01 | 6.0 | 12 | 2 | 49,838 | 4,086 |
| 2022-03-01 | 0.7708 | 37 | 48 | 824,997 | 525,864 |
| 2021-06-01 | 1.3571 | 19 | 14 | 50,084 | 91,883 |
| 2021-03-01 | 0.527 | 39 | 74 | 391,101 | 606,663 |
| 2020-12-01 | 0.1111 | 4 | 36 | 1,680 | 253,418 |
| 2020-09-01 | 0.75 | 24 | 32 | 122,662 | 275,138 |
| 2020-06-01 | 2.5 | 5 | 2 | 97,183 | 36,948 |
| 2020-03-01 | 0.875 | 21 | 24 | 422,834 | 220,575 |
| 2019-12-01 | 0.2857 | 6 | 21 | 24,401 | 212,887 |
| 2019-09-01 | 0.7083 | 17 | 24 | 101,455 | 127,720 |
| 2019-06-01 | 0.4545 | 5 | 11 | 51,272 | 161,500 |
| 2019-03-01 | 0.6154 | 32 | 52 | 1,489,381 | 1,430,421 |
| 2018-12-01 | 0.1765 | 3 | 17 | 171,936 | 524,631 |
| 2018-09-01 | 1.1 | 11 | 10 | 55,508 | 46,990 |
| 2018-06-01 | 1.0 | 7 | 7 | 92,597 | 32,989 |
| 2018-03-01 | 0.6324 | 43 | 68 | 1,065,416 | 1,229,411 |
| 2017-12-01 | 0.3043 | 7 | 23 | 564,265 | 1,271,391 |
| 2017-09-01 | 2.0 | 34 | 17 | 1,197,844 | 297,503 |
| 2017-06-01 | 1.6667 | 5 | 3 | 16,608 | 19,936 |
| 2017-03-01 | 0.5484 | 17 | 31 | 213,013 | 302,185 |
| 2016-12-01 | 0.5294 | 9 | 17 | 1,588,124 | 3,126,439 |
| 2016-09-01 | 1.6667 | 15 | 9 | 239,000 | 128,433 |
| 2016-06-01 | 1.1429 | 8 | 7 | 501,361 | 537,502 |
| 2016-03-01 | 0.9697 | 32 | 33 | 1,654,146 | 635,121 |
| 2015-12-01 | 1.2 | 6 | 5 | 165,839 | 164,598 |
| 2015-09-01 | 1.5 | 12 | 8 | 168,454 | 124,084 |
| 2015-06-01 | 0.6667 | 2 | 3 | 2,177 | 10,640 |
| 2015-03-01 | 1.0556 | 19 | 18 | 527,333 | 123,650 |
| 2014-12-01 | 0.5641 | 22 | 39 | 807,811 | 2,082,477 |
| 2014-09-01 | 1.5714 | 11 | 7 | 169,109 | 107,291 |
| 2014-06-01 | 2.3333 | 7 | 3 | 148,464 | 133,766 |
| 2014-03-01 | 1.2 | 12 | 10 | 475,825 | 61,359 |
| 2013-12-01 | 1.2222 | 11 | 9 | 215,459 | 124,699 |
| 2013-09-01 | 3.2 | 16 | 5 | 380,448 | 69,873 |
| 2013-06-01 | 4.0 | 4 | 1 | 23,378 | 3,577 |
| 2013-03-01 | 4.5 | 9 | 2 | 429,950 | 55,695 |
| 2012-12-01 | 1.0 | 9 | 9 | 84,987 | 113,607 |
| 2012-09-01 | 13.0 | 13 | 1 | 64,308 | 4,608 |
| 2012-06-01 | 1.0 | 2 | 2 | 5,223 | 5,356 |
| 2012-03-01 | 1.3333 | 4 | 3 | 397,500 | 5,310 |
| 2011-12-01 | 0.875 | 7 | 8 | 304,401 | 106,092 |
| 2011-09-01 | 3.8 | 19 | 5 | 183,923 | 30,038 |
| 2011-03-01 | 1.0 | 1 | 1 | 300,000 | 0.00 |
| 2010-09-01 | 7.0 | 21 | 3 | 252,866 | 10,167 |
| 2010-03-01 | 1.4 | 7 | 5 | 51,461 | 17,155 |
| 2009-09-01 | 9.0 | 9 | 1 | 646,373 | 0.00 |
| 2009-03-01 | 0.2 | 3 | 15 | 1,374,999 | 895,000 |
| 2008-12-01 | 1.0 | 1 | 1 | 130,000 | 0.00 |
| 2005-03-01 | 3.0 | 3 | 1 | 155,000 | 20,000 |
| 2004-12-01 | 6.0 | 6 | 1 | 280,000 | 20,000 |
EXACT Sciences Notable Stakeholders
An EXACT Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EXACT Sciences often face trade-offs trying to please all of them. EXACT Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EXACT Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kevin Conroy | Chairman of The Board, CEO and Pres | Profile | |
| Kevin JD | Chairman CEO | Profile | |
| Nicole Maassen | Market President | Profile | |
| Scott Coward | Sr. VP and General Counsel | Profile | |
| Graham Lidgard | Chief Science Officer and Sr. VP | Profile | |
| James Herriott | General VP | Profile | |
| Wayne Taylor | Head VP | Profile | |
| Ana Hooker | Chief Officer | Profile | |
| Aaron Bloomer | Executive Finance | Profile | |
| Vic Parker | Head Sales | Profile | |
| Sri Kalluri | Chief Officer | Profile | |
| Nassar Nizami | Chief Officer | Profile | |
| Jake MBA | Executive Screening | Profile | |
| Jorge Garces | Chief Officer | Profile | |
| Jeffrey CFA | Chief Officer | Profile | |
| Erik Holznecht | Senior Associate | Profile | |
| Derek Leckow | Vice Relations | Profile | |
| Jacob MBA | Executive Screening | Profile | |
| Steven Bellamy | Chief Region | Profile | |
| Sarah Condella | Executive Resources | Profile | |
| Tim Caprez | Chief VP | Profile | |
| Brian Baranick | Executive Oncology | Profile | |
| Vamsi Pudipeddi | Chief Officer | Profile | |
| Everett Cunningham | Chief Officer | Profile | |
| Frederick MD | Chief Oncology | Profile | |
| MD FACP | Chief Detection | Profile | |
| Megan Jones | Associate Relations | Profile | |
| MPH MD | Chief Screening | Profile |
About EXACT Sciences Management Performance
The success or failure of an entity such as EXACT Sciences often depends on how effective the management is. EXACT Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of EXACT management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the EXACT management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.40) | (0.42) | |
| Return On Capital Employed | (0.20) | (0.21) | |
| Return On Assets | (0.17) | (0.18) | |
| Return On Equity | (0.43) | (0.45) |
Please note, the imprecision that can be found in EXACT Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EXACT Sciences. Check EXACT Sciences' Beneish M Score to see the likelihood of EXACT Sciences' management manipulating its earnings.
EXACT Sciences Workforce Analysis
Traditionally, organizations such as EXACT Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EXACT Sciences within its industry.EXACT Sciences Manpower Efficiency
Return on EXACT Sciences Manpower
| Revenue Per Employee | 399.8K | |
| Revenue Per Executive | 98.5M | |
| Net Loss Per Employee | 149.1K | |
| Net Loss Per Executive | 36.7M | |
| Working Capital Per Employee | 121.6K | |
| Working Capital Per Executive | 30M |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.